The reality is the sector is exploding
and the big boys have plenty of extra cash to spend now,
Here is the amount of cash drugmakers have to repatriate to the USA as part of tax reform,
AMGEN- $US 39 BILLION
GILEAD- $US 32 BILLION
PFIZER- $US 22 BILLION
MERCK- $US 20 BILLION
J and J- $US 14 BILLION
ABBVIE- $US 10 BILLION
LILLY- $US 9 BILLION
BMS- $US 9 BILLION
CELGENE- $US 9 BILLION
BIOGEN- $US 4 BILLION
there is a reality check for ya,
Add to My Watchlist
What is My Watchlist?
